3 ms·
I expect most of the cost is regulatory. Lighter regulation around rare "small market" diseases might save a lot of lives. And money.
by BurningFrog 5y ago
I expect most of the cost is regulatory.
Lighter regulation around rare "small market" diseases might save a lot of lives. And money.
- soldehierro 5y ago> Lighter regulation around rare "small market" diseases might save a lot of lives. And money. Orphan drugs for rare diseases are already subject to less regulation.